The average P/S ratio for CLBT's competitors is 6.21, providing a benchmark for relative valuation. Cellebrite DI Ltd Corp (CLBT) exhibits a P/S ratio of 6.85, which is 10.25% above the industry average. Given its robust revenue growth of 20.06%, this premium appears sustainable.